MARKET

ONVO

ONVO

Organovo Holdings
NASDAQ

Real-time Quotes | Nasdaq Last Sale

10.77
-0.62
-5.44%
Opening 15:36 03/05 EST
OPEN
11.41
PREV CLOSE
11.39
HIGH
11.84
LOW
9.34
VOLUME
324.47K
TURNOVER
--
52 WEEK HIGH
23.92
52 WEEK LOW
3.866
MARKET CAP
76.65M
P/E (TTM)
-4.1897
1D
5D
1M
3M
1Y
5Y
3D Printing Medical Devices Market Industry Size study, By Players – Analysis and Current Growth Analysis 2021 – 2025 | Says Kenneth Research
Mar 04, 2021 (AmericaNewsHour) -- Recently, a significant growth in healthcare spending have been observed in the low- and middle-income nations. In the...
AmericaNewsHour · 1d ago
Benzinga's Interview With ARK Invest's Cathie Wood About To Be Live On Benzinga's YouTube!
https://www.youtube.com/watch?v=NUehKZBLBCQ
Benzinga · 2d ago
Global MENA Healthcare 3D Printing Market Outlook, Industry Analysis and Prospect 2019-2025
Mar 03, 2021 (Heraldkeepers) -- COMTEX_382082343/2582/2021-03-03T13:48:50 Is there a problem with this press release? Contact the source provider Comtex at...
Heraldkeepers · 2d ago
Global North America Market Outlook, Industry Analysis and Prospect 2018-2024
Mar 03, 2021 (Heraldkeepers) -- North America holds prominent share in 3D printing market as it is fast gaining preference over traditional manufacturing...
Heraldkeepers · 2d ago
3D Printing in Healthcare Market 2021 Opportunities, Size, 3D Printing in Healthcare Market Emerging Trends, Technological Innovation And Forecasts To 2025 Kennethresearch.com
Mar 03, 2021 (AmericaNewsHour) -- Kenneth Research has published a detailed report on 3D Printing in Healthcare Market, which has been categorized by market...
AmericaNewsHour · 2d ago
Organovo Announces Participation at the H.C. Wainwright Global Life Sciences Conference March 9-10 2021 (VIRTUAL CONFERENCE)
GlobeNewswire · 3d ago
Europe Healthcare 3D Printing Market Share, Size Global Growth Prospects, Growth, Trends, Industry Analysis, Key Players and Forecast to 2024
Mar 02, 2021 (The Expresswire) -- Global Europe Healthcare 3D Printing Market research report provides a Point-by-Point In-Depth analysis of global market...
The Express Wire · 3d ago
Organ-on-a-chip Market Size 2021 By Share, Industry Statistics, Trends Evaluation, Business Challenges and Investment Opportunities Analysis till 2026
Mar 01, 2021 (The Expresswire) -- The report provides revenue of the globalOrgan-on-a-chip Market for the period 2016 and 2026, considering 2020 as the base...
The Express Wire · 4d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ONVO. Analyze the recent business situations of Organovo Holdings through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ONVO stock price target is 3.000 with a high estimate of 3.000 and a low estimate of 3.000.
EPS
Institutional Holdings
Institutions: 147
Institutional Holdings: 6.57M
% Owned: 92.32%
Shares Outstanding: 7.12M
TypeInstitutionsShares
Increased
9
50.02K
New
14
2.62K
Decreased
8
100.14K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.96%
Pharmaceuticals & Medical Research
+1.28%
Key Executives
Chairman/Chief Financial Officer/Executive Director
Keith Murphy
President/Chief Financial Officer
Chris Heberlig
Chief Scientific Officer
Jeffrey Miner
General Counsel
Thomas Jurgensen
Other
Steven Hughes
Independent Director
Douglas Cohen
Independent Director
David Gobel
Independent Director
Alison Milhous
Independent Director
Adam Stern
No Data
About ONVO
Organovo Holdings, Inc. is an early commercial-stage company focused on developing and commercializing functional human tissues. The Company focuses on the generation of three-dimensional (3D) human tissues, by utilizing its platform technology to create human tissue constructs in 3D. It is focused on development of products, including 3D human tissues used for the preclinical assessment of drug effects, including applications in predictive toxicology, absorption, distribution, metabolism, excretion (ADME), and drug metabolism and pharmacokinetics (DMPK); customized human tissues as living, dynamic models of human biology or disease, for use in drug discovery and development, and three-dimensional human tissues for clinical applications, such as blood vessels for bypass grafting, nerve grafts for nerve damage repair and functional tissue patches for the repair or replacement of damaged tissues and organs.

Webull offers kinds of Organovo Holdings Inc stock information, including NASDAQ:ONVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ONVO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ONVO stock methods without spending real money on the virtual paper trading platform.